Dexcom ONE+: Glycemic Flux & Prediabetes Reversal

In the Guesswork Era, prediabetes management relied on a single number — a quarterly HbA1c that mathematically averaged away the metabolic damage occurring daily. In the 2026 Consensus, we recognise that Glycemic Flux — the amplitude, frequency, and circadian patterning of glucose movement — cannot be managed from a number that updates every 90 days. A fasting glucose reading tells you nothing about what happens at 21:00 after a “healthy” meal, or at 06:00 when cortisol initiates its morning activation sequence. The Dexcom ONE+ was deployed to answer one question: where, exactly, is the metabolic architecture breaking down?

01. The Objective

Standard prediabetes management relies on spot-checks — finger-prick tests that capture a single moment in an otherwise invisible 24-hour metabolic timeline. For the Biohack Forge Protocol, this is insufficient.

To reverse the aging drift associated with chronic insulin resistance, we require a continuous stream of metadata capable of mapping Glycemic Flux — the amplitude, frequency, and circadian patterning of glucose movement throughout the day. A single fasting number cannot reveal what happens postprandially, nocturnally, or across the cortisol-driven transition from sleep to waking.

The Dexcom ONE+ was deployed to answer one question: where, exactly, is the metabolic architecture breaking down?

02. The Catalyst

A routine HbA1c blood panel returned a value of 42 mmol/mol (6.0%) — within the prediabetic range of 42 to 47 mmol/mol (6.0% to 6.4%) and enough to constitute a system-level warning. Fasting glucose had been fluctuating between $5.2–5.5\ mmol/L$ for 12 months, dismissed by standard clinical review as “borderline but manageable.”

The Forge Protocol does not accept “manageable” as an outcome. Prediabetes, left unaddressed, is a confirmed accelerant of the DunedinPACE biological aging clock. This briefing documents the 90-day hardware deployment that assisted in reversing the trajectory.

03. Hardware Architecture

Upgrade Delta

The Dexcom ONE+ (UK release, 2024–25) represents a meaningful upgrade over the previous Dexcom ONE in two operationally critical areas.

Sensor Warm-Up: 30 minutes (reduced from 2 hours). For a protocol that requires metabolic data to be active before the first meal, this matters. A 2-hour blind window at sensor swap was a structural flaw in the previous generation — one that made circadian baseline capture at 06:00 unreliable on swap days.

12-Hour Grace Period on Sensor Swaps. Eliminates the overnight data gap that previously occurred when a 10-day sensor expired during sleep. Continuity of data is non-negotiable for circadian pattern analysis; a recurring nocturnal blind window would have made the Dawn Phenomenon findings in Section 05B unpublishable.

Form Factor and Protocol Compatibility

The reduced profile allowed continuous 24/7 deployment without interfering with Pillar 02: Physical Architecture training loads — including weighted rucking and resistance sessions where sensor adhesion was previously a point of concern with the original ONE form factor. No sensor losses occurred across the 90-day audit period attributable to physical training.

Cross-Validation Method

The ONE+ was cross-referenced against capillary blood glucose (Keto-Mojo GK+) at key metabolic junctions — fasted, postprandial peak, and post-exercise — to validate sensor accuracy. Average deviation: $\pm0.3\ mmol/L$ . Within acceptable tolerance for protocol-grade decisions.

04. Protocol Methodology

Duration: 90 days continuous.

Data Capture Windows:

Fasted baseline: 06:00–07:00 daily
Postprandial monitoring: 30, 60, and 120 minutes post each primary meal
Post-exercise window: 0–45 minutes after all Pillar 02 sessions
Nocturnal: passive capture via Dexcom app + overnight alerts set at $>8.5\ mmol/L$

Cross-Pillar Integration:

Pillar 02 (Physical Architecture): Post-meal Zone 1 walk protocol was designed in conjunction with Pillar 02 training loads; GLUT4 translocation data informed resistance session timing relative to meals.
Pillar 05 (The Biological Roadmap): CGM data was used to project rolling predicted HbA1c against Consensus 14 targets.

Interventions Tested (sequentially, not simultaneously, to isolate variables):

Post-meal 15-minute Zone 1 walk
Carbohydrate timing shift to the Metabolic Window (11:00–15:00)
Elimination of wheat-based complex carbohydrates after 17:00
Macronutrient Restructuring: Transition to a low-carbohydrate baseline ( $<75g$ daily net carbs), prioritising fats and proteins for basal energy.

Confounders Acknowledged:

Concurrent dietary changes across the same 90-day window were controlled through sequential testing, but precise macro tracking was observational rather than laboratory-grade.
Seasonal variation in physical activity (winter to spring transition) may have contributed modestly to improved insulin sensitivity independent of dietary interventions.
Stress-related cortisol variance was not systematically tracked and may have introduced noise in Dawn Phenomenon amplitude readings across the audit window.

05. Metadata Findings

A. The Hidden Spike Phenomenon

Fasting glucose consistently appeared within the normal range ( $5.2–5.5\ mmol/L$ ) on finger-prick tests — the exact data point a standard GP review would use to classify the metabolic situation as stable. The CGM told a different story.

Postprandial excursions following “healthy” meals — whole-wheat pasta, brown rice, oat-based breakfasts — were reaching $9.1–9.8\ mmol/L$ within 45 minutes. These spikes, invisible to spot-check testing, were occurring 2–3 times daily.

Clinical implication: Prediabetes is frequently a disease of amplitude before it becomes a disease of averages. An HbA1c of 6.0% is the mathematical average of a glycemic range that includes multiple daily excursions into the $9–10\ mmol/L$ zone. Treating the average number without addressing the spike architecture is treating the symptom, not the mechanism.

Protocol decision: All postprandial excursions above $8.0\ mmol/L$ were logged with full meal composition notes, generating a food-response matrix that directly drove the carbohydrate elimination sequence in Interventions 3 and 4.

B. Circadian Glycemic Sensitivity

The CGM logged a consistent Dawn Phenomenon — a cortisol-driven glucose rise of $0.8–1.2\ mmol/L$ occurring between 05:30–07:00 without any food intake. This is a well-documented hepatic glucose output response to morning cortisol activation, but the magnitude confirmed above-average insulin resistance.

More actionable: insulin sensitivity showed a clear circadian gradient. Identical carbohydrate loads produced:

60-minute post-meal peak at 13:00: $7.1\ mmol/L$
60-minute post-meal peak at 20:00: $9.4\ mmol/L$

Same food. Same portion. $2.3\ mmol/L$ difference based on time of day alone.

Protocol decision: The remaining 70% of the newly reduced daily carbohydrate intake was strictly confined to the Metabolic Window (11:00–15:00), aligning glycemic loads with peak insulin sensitivity. Evening meals were entirely stripped of starchy carbohydrates and restructured exclusively around high-quality protein and fibrous, above-ground vegetables.

C. Muscle as a Glucose Sink

The single highest-leverage intervention identified in the 90-day dataset was the Post-Meal Walk Protocol — a 10–15 minute Zone 1 walk initiated within 10–15 minutes of completing the evening meal.

Average peak glucose reduction: 22% compared to sedentary post-meal periods.

The mechanism: skeletal muscle contraction activates GLUT4 transporter translocation via an insulin-independent pathway, effectively shunting circulating glucose into the Structural Chassis (Pillar 02) before it can trigger the downstream inflammatory cytokine response associated with chronic hyperglycaemia.

Protocol decision: The post-meal walk was codified as a non-negotiable evening protocol element — zero cost, zero equipment — and produced the largest single-variable improvement in Time in Range across the entire audit.

D. The Low-Carb Baseline Shift

While the Zone 1 walks provided acute glucose disposal, the transition to a low-carbohydrate architecture ( $<75g$ daily) provided the structural fix.

By reducing high-glycemic loads at source, the amplitude of postprandial excursions was blunted before they could occur. This intervention was the primary driver in halving Glycemic Variability (GV) from $2.4\ mmol/L$ to $1.1\ mmol/L$ . The metabolic system was no longer spending biological energy managing glucose influxes or the subsequent reactive hypoglycaemic crashes. Baseline insulin levels were permitted to remain functionally low throughout the 24-hour cycle, facilitating sustained fat oxidation and reducing Systemic Load across all Forge Pillars.

Protocol decision: A daily carbohydrate ceiling of $<75g$ net carbs was adopted as the permanent baseline architecture, replacing the previous mixed-macronutrient template entirely.

06. Consensus 14 Outcomes

Marker	Baseline	Optimised	Status
Glycemic Variability (GV)	$2.4\ mmol/L$	$1.1\ mmol/L$	▲ Resolved
Time in Range (3.9–7.8 mmol/L)	65%	90%	▲ Optimised
HbA1c / GMI	42 mmol/mol (Prediabetic)	37 mmol/mol (Normal)	▲ Reversed
Postprandial Peak (avg)	$9.2\ mmol/L$	$7.0\ mmol/L$	▲ Controlled
Dawn Phenomenon Amplitude	$1.1\ mmol/L$	$0.6\ mmol/L$	▲ Attenuated

Forge Verdict: Five markers moved in 90 days without pharmaceutical intervention — driven entirely by continuous data that standard clinical monitoring would never have captured. The hidden spike architecture was the mechanism; the CGM was the diagnostic. Without continuous glycemic intelligence, every one of these protocol decisions would have been operating blind against a fasting glucose reading that consistently registered as normal.

Protocol Status: ADOPTED

The Dexcom ONE+ is confirmed as an Adopted tool within the Biohack Forge Protocol 1.0. It provides real-time fuel efficiency tracking and is designated as entry-level hardware for any individual initiating the Metabolic Intelligence phase of the Longevity Roadmap.

The data generated by this device is not supplementary — it is the foundation upon which all carbohydrate, timing, and exercise protocol decisions are made. Without intervals of continuous glycemic intelligence, every metabolic intervention is operating blind. A follow-up report will be issued at the 180-day mark to assess long-term HbA1c trajectory and evaluate whether the $<75g$ carbohydrate baseline requires seasonal or training-load adjustment.